fenclonine has been researched along with Conus Medullaris Syndrome in 1 studies
Fenclonine: A selective and irreversible inhibitor of tryptophan hydroxylase, a rate-limiting enzyme in the biosynthesis of serotonin (5-HYDROXYTRYPTAMINE). Fenclonine acts pharmacologically to deplete endogenous levels of serotonin.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Siegal, T | 2 |
1 other study available for fenclonine and Conus Medullaris Syndrome
| Article | Year |
|---|---|
Serotonergic manipulations in experimental neoplastic spinal cord compression.
Topics: Animals; Capillary Permeability; Cyproheptadine; Dexamethasone; Dinoprostone; Dose-Response Relation | 1993 |